Practice Point CME

Your Sorted CME/CE Activities

Number of search result: 8

Conversations in PAH (Episode 3) - Past and Future Challenges of WSPH; Cardiopulmonary Exercise Testing in PH and The Unmet Clinical Needs in SSc-PAH

Activity Details

Conversations in PAH (Episode 3) - Past and Future Challenges of WSPH; Cardiopulmonary Exercise Testing in PH and The Unmet Clinical Needs in SSc-PAH

Activity Summary:
This accredited continuing education activity features a recorded discussion among three experts and is designed to keep healthcare professionals abreast of the most recent clinical findings in pulmonary arterial hypertension (PAH).

In this edition, Dr. Ronald Oudiz, Dr. Aaron Waxman and Dr. Marius Hoeper discuss past and future challenges of the World Symposium on Pulmonary Hypertension (WSPH), cardiopulmonary exercise testing in PH and the unmet clinical needs in systemic sclerosis-associated PAH (SSc-PAH).

Faculty:Ronald Oudiz, MD, FACP, FACC, FCCP, Aaron B. Waxman, MD, PhD and Marius Hoeper, MD

Accreditation Type:AMA, ANCC and ACPE

Launch Date:September 23, 2021

Release Date:September 3, 2021

Expiration Date: August 31, 2022

Estimated Time to Complete Activity:1 hour

ACCESS THIS ACTIVITY

Conversations in PAH: 2021 Congress Highlights, Intensive Care & COVID-19, and Recent Updates in CTEPH

Activity Details

Conversations in PAH: 2021 Congress Highlights, Intensive Care & COVID-19, and Recent Updates in CTEPH

Activity Summary:
This AMA/ANCC/ACPE activity features a recorded discussion among three experts and is designed to keep healthcare professionals abreast the most recent clinical findings in PAH.

The second edition will feature Dr. Ronald Oudiz, Dr. Nicholas Hill and Dr. Richard Channick discussing congress highlights from the International Society for Heart and Lung Transplantation and American Thoracic Society 2021, intensive care management of the PAH patient with COVID-19 and recent updates to the medical management of patients with CTEPH.

Faculty:Ronald Oudiz, MD, FACP, FACC, FCCP, Richards Channick, MD and Nicholas Hill, MD

Accreditation Type:AMA, ANCC and ACPE

Launch Date:June 21, 2021

Release Date:June 21, 2021

Expiration Date: May 31, 2022

Estimated Time to Complete Activity:1 hour

ACCESS THIS ACTIVITY

Conversations in PAH: COVID-19 & PAH, Current and Emerging Treatments

Activity Details

Conversations in PAH: COVID-19 & PAH, Current and Emerging Treatments

Activity Summary:
This AMA/ANCC/ACPE activity features a recorded discussion among three experts and is designed to keep healthcare professionals on top of the most recent clinical findings in PAH.

The first edition will feature Dr. Ronald Oudiz, Dr. Murali Chakinala and Dr. Harrison Farber discussing updates on COVID-19 & PAH and recent treatment strategies of PAH and emerging research for 2021.

Faculty:Ronald Oudiz, MD, FACP, FACC, FCCP, Murali Chakinala, MD, FCCP and Harrison Farber, MD

Accreditation Type:AMA, ANCC and ACPE

Launch Date:May 3, 2021

Release Date:April 12, 2021

Expiration Date: April 30, 2022

Estimated Time to Complete Activity:1 hour

ACCESS THIS ACTIVITY

Conversations in PAH: An Expert Discussion on Clinical Updates and Treatment Options in PAH

Activity Details

Conversations in PAH: An Expert Discussion on Clinical Updates and Treatment Options in PAH

Activity Summary:
Conversations in PAH are accredited, on-demand video presentations that feature PAH experts discussing hot topics, recent clinical updates, conference updates and treatment options for managing patients with PAH. This activity is designed to keep healthcare professionals on top of the most recent clinical findings in PAH. A new video series will be released every quarter throughout 2021.

Faculty:Various Faculty

Accreditation Type:AMA, ANCC and ACPE

Launch Date:

Release Date:

Expiration Date:

Estimated Time to Complete Activity:1 Hour per Module

ACCESS THIS ACTIVITY

Women and Stable Ischemic Heart Disease

Activity Details

Women and Stable Ischemic Heart Disease

Activity Summary:
In the past decade, it has become increasingly clear that women and men with stable ischemic heart disease often present with different signs and symptoms. Some of these differences can reflect gender-based differences in disease pathophysiology and risks for clinical cardiovascular events, as well as the need for different diagnostic methods and treatment strategies.

These educational Mini Modules will outline the epidemiologic trends as well as the health and economic burden of SIHD in women. In addition, discussion will include gender-specific pathophysiologic factors in SIHD, diagnostic approaches, risk stratification, and management approaches in women with stable ischemic heart disease.

Faculty:Nanette Wenger, MD, MACC, MACP, FAHA

Accreditation Type:Expired Activity

Launch Date:Expired Activity

Release Date:Expired Activity

Expiration Date: Expired Activity

Estimated Time to Complete Activity:Expired Activity

ACCESS THIS ACTIVITY

Reducing CV Events and Mortality in Stable Ischemic Heart Disease

Activity Details

Reducing CV Events and Mortality in Stable Ischemic Heart Disease

Activity Summary:
Reducing the risk of death and major cardiovascular events are major goals of therapy for people with stable ischemic heart disease. Many management decisions hinge on a patient’s risk for these events, and recent and ongoing trials are helping to clarify treatment decisions in patients in different risk categories.

These educational Mini Modules will outline the role of medical therapies and revascularization when the goal of therapy is to reduce cardiovascular events and improve survival.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Faculty:William Boden, MD

Accreditation Type:Expired Activity

Launch Date:Expired Activity

Release Date:Expired Activity

Expiration Date: Expired Activity

Estimated Time to Complete Activity:Expired Activity

ACCESS THIS ACTIVITY

Managing Symptoms of Stable Ischemic Heart Disease

Activity Details

Managing Symptoms of Stable Ischemic Heart Disease

Activity Summary:
Major goals of therapy for people with stable ischemic heart disease (SIHD) include reducing angina symptoms and improving functional ability and quality of life. Recent developments in the use of medical therapies and re-evaluations of older therapies have brought some important changes to the treatment of these patients. Application of the results of revascularization trials and current recommendations requires careful and skillful risk stratification as well as a thorough understanding of the trial designs and results.

These educational Mini Modules will outline how recent developments and clinical trials influence the management of symptoms and functional limitations in real-world patients with stable ischemic heart disease.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Faculty:Michelle O’Donoghue, MD

Accreditation Type:Expired Activity

Launch Date:Expired Activity

Release Date:Expired Activity

Expiration Date: Expired Activity

Estimated Time to Complete Activity:Expired Activity

ACCESS THIS ACTIVITY

Diabetes and Stable Ischemic Heart Disease

Activity Details

Diabetes and Stable Ischemic Heart Disease

Activity Summary:
Diabetes is a strong risk factor for cardiovascular disease, and it influences management and outcomes of existing disease.

These educational Mini Modules will outline how diabetes influences the onset and management of stable ischemic heart disease (SIHD), including choices of medical therapies and decisions about the use of revascularization strategies.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Faculty:Bernard Chaitman, MD

Accreditation Type:Expired Activity

Launch Date:Expired Activity

Release Date:Expired Activity

Expiration Date: Expired Activity

Estimated Time to Complete Activity:Expired Activity

ACCESS THIS ACTIVITY

CME/CE Activity Sorter
(Select therapeutic category and activity type of interest and view your sorted activities below)

Your Sorted CME/CE Activities

Conversations in PAH (Episode 3) - Past and Future Challenges of WSPH; Cardiopulmonary Exercise Testing in PH and The Unmet Clinical Needs in SSc-PAH

Conversations in PAH: 2021 Congress Highlights, Intensive Care & COVID-19, and Recent Updates in CTEPH

Conversations in PAH: COVID-19 & PAH, Current and Emerging Treatments

Conversations in PAH: An Expert Discussion on Clinical Updates and Treatment Options in PAH

Women and Stable Ischemic Heart Disease

Reducing CV Events and Mortality in Stable Ischemic Heart Disease

Managing Symptoms of Stable Ischemic Heart Disease

Diabetes and Stable Ischemic Heart Disease